EP1007073A4 - PROCEDURES FOR EATING HABITS, COMPOUNDS SUITABLE FOR THESE PROCEDURES, AND DNA ENCODING A HYPOTHALAMIC ATYPICAL NEUROPEPTIDE Y / PEPTIDE YY RECEPTOR - Google Patents

PROCEDURES FOR EATING HABITS, COMPOUNDS SUITABLE FOR THESE PROCEDURES, AND DNA ENCODING A HYPOTHALAMIC ATYPICAL NEUROPEPTIDE Y / PEPTIDE YY RECEPTOR

Info

Publication number
EP1007073A4
EP1007073A4 EP97928786A EP97928786A EP1007073A4 EP 1007073 A4 EP1007073 A4 EP 1007073A4 EP 97928786 A EP97928786 A EP 97928786A EP 97928786 A EP97928786 A EP 97928786A EP 1007073 A4 EP1007073 A4 EP 1007073A4
Authority
EP
European Patent Office
Prior art keywords
procedures
hypothalamic
neuropeptide
atypical
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97928786A
Other languages
German (de)
French (fr)
Other versions
EP1007073A1 (en
Inventor
Christophe P G Gerald
Richard L Weinshank
Mary W Walker
Theresa Branchek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lundbeck Research USA Inc
Original Assignee
Synaptic Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/668,650 external-priority patent/US5989920A/en
Application filed by Synaptic Pharmaceutical Corp filed Critical Synaptic Pharmaceutical Corp
Publication of EP1007073A1 publication Critical patent/EP1007073A1/en
Publication of EP1007073A4 publication Critical patent/EP1007073A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP97928786A 1996-06-04 1997-06-04 PROCEDURES FOR EATING HABITS, COMPOUNDS SUITABLE FOR THESE PROCEDURES, AND DNA ENCODING A HYPOTHALAMIC ATYPICAL NEUROPEPTIDE Y / PEPTIDE YY RECEPTOR Withdrawn EP1007073A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/668,650 US5989920A (en) 1994-12-02 1996-06-04 Methods of modifying feeding behavior compounds useful in such methods and DNA encoding a hypothalmic atypical neuropeptide Y/peptide YY receptor Y5
US668650 1996-06-04
US80360097A 1997-02-21 1997-02-21
US803600 1997-02-21
PCT/US1997/009504 WO1997046250A1 (en) 1996-06-04 1997-06-04 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)

Publications (2)

Publication Number Publication Date
EP1007073A1 EP1007073A1 (en) 2000-06-14
EP1007073A4 true EP1007073A4 (en) 2002-03-27

Family

ID=27099966

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97928786A Withdrawn EP1007073A4 (en) 1996-06-04 1997-06-04 PROCEDURES FOR EATING HABITS, COMPOUNDS SUITABLE FOR THESE PROCEDURES, AND DNA ENCODING A HYPOTHALAMIC ATYPICAL NEUROPEPTIDE Y / PEPTIDE YY RECEPTOR

Country Status (3)

Country Link
EP (1) EP1007073A4 (en)
AU (1) AU3295297A (en)
WO (1) WO1997046250A1 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602024A (en) 1994-12-02 1997-02-11 Synaptic Pharmaceutical Corporation DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof
US5989920A (en) 1994-12-02 1999-11-23 Synaptic Pharmaceutical Corporation Methods of modifying feeding behavior compounds useful in such methods and DNA encoding a hypothalmic atypical neuropeptide Y/peptide YY receptor Y5
AUPN646795A0 (en) 1995-11-09 1995-11-30 Garvan Institute Of Medical Research Neuropeptide Y-Y5 receptor
US6713265B1 (en) 1997-06-04 2004-03-30 Synaptic Pharmaceutical Corporation Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
SE9703414D0 (en) * 1997-09-23 1997-09-23 Astra Ab New compounds
ATE314371T1 (en) 1998-11-10 2006-01-15 Merck & Co Inc SPIRO-INDOLE AS Y5 RECEPTOR ANTAGONISTS
WO2000063171A1 (en) 1999-04-20 2000-10-26 Meiji Seika Kaisha, Ltd. Tricyclic compounds
CA2403307A1 (en) 2001-10-23 2003-04-23 Neurogen Corporation Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives
NZ534757A (en) 2002-03-12 2006-07-28 Merck & Co Inc Substituted amides
WO2004066966A2 (en) 2003-01-17 2004-08-12 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Peptide yy analogs
JP2004315511A (en) * 2003-03-31 2004-11-11 Taisho Pharmaceut Co Ltd MCH receptor antagonist
JP4806628B2 (en) 2003-05-05 2011-11-02 プロビオドルグ エージー Glutaminyl cyclase inhibitor
EP2338490A3 (en) 2003-11-03 2012-06-06 Probiodrug AG Combinations useful for the treatment of neuronal disorders
US7304086B2 (en) 2004-02-05 2007-12-04 Probiodrug Ag Inhibitors of glutaminyl cyclase
US8193206B2 (en) 2005-06-14 2012-06-05 Taigen Biotechnology Co., Ltd. Pyrimidine compounds
JP5118029B2 (en) 2005-06-14 2013-01-16 タイゲン バイオテクノロジー カンパニー,リミテッド Pyrimidine compounds
EP2089383B1 (en) 2006-11-09 2015-09-16 Probiodrug AG 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
US9126987B2 (en) 2006-11-30 2015-09-08 Probiodrug Ag Inhibitors of glutaminyl cyclase
AU2008220785B2 (en) 2007-03-01 2013-02-21 Vivoryon Therapeutics N.V. New use of glutaminyl cyclase inhibitors
JP5667440B2 (en) 2007-04-18 2015-02-12 プロビオドルグ エージー Thiourea derivatives as glutaminyl cyclase inhibitors
AU2008355098B2 (en) 2008-04-21 2012-11-15 Gpcr Therapeutics, Inc Heterocyclic compounds
US20090298834A1 (en) * 2008-06-02 2009-12-03 Hassan Pajouhesh 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers
WO2010056847A2 (en) 2008-11-13 2010-05-20 Taigen Biotechnology Co., Ltd. Lyophilization formulation
JP5934645B2 (en) 2009-09-11 2016-06-15 プロビオドルグ エージー Heterocyclic derivatives as glutaminyl cyclase inhibitors
WO2011107530A2 (en) 2010-03-03 2011-09-09 Probiodrug Ag Novel inhibitors
JP5688745B2 (en) 2010-03-10 2015-03-25 プロビオドルグ エージー Heterocyclic inhibitor of glutaminyl cyclase (QC, EC 2.3.2.5)
WO2011131748A2 (en) 2010-04-21 2011-10-27 Probiodrug Ag Novel inhibitors
EP2686313B1 (en) 2011-03-16 2016-02-03 Probiodrug AG Benzimidazole derivatives as inhibitors of glutaminyl cyclase
ES2812698T3 (en) 2017-09-29 2021-03-18 Probiodrug Ag Glutaminyl cyclase inhibitors
CN114340670B (en) 2019-07-11 2026-02-17 普拉克西斯精密药物股份有限公司 Formulations and administration of T-type calcium channel modulators
PL448201A1 (en) * 2024-04-05 2025-10-06 Politechnika Krakowska im. Tadeusza Kościuszki New derivatives of N-{6-[(3,4-dihydroquinazolin-2-yl)amino]hexyl}naphthalene-sulfonamides, method of their preparation and their use

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996016542A1 (en) * 1994-12-02 1996-06-06 Synaptic Pharmaceutical Corporation Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)
WO1997017440A1 (en) * 1995-11-09 1997-05-15 Garvan Institute Of Medical Research Neuropeptide y-y5 receptor
WO1997020822A1 (en) * 1995-12-01 1997-06-12 Novartis Ag Quinazolin-2,4-diazirines as npy receptor antagonist
WO1997020820A1 (en) * 1995-12-01 1997-06-12 Novartis Ag Heteroaryl compounds
WO1997037998A2 (en) * 1996-04-08 1997-10-16 Bayer Corporation Neuropeptide y receptor y5 and nucleic acid sequence

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996016542A1 (en) * 1994-12-02 1996-06-06 Synaptic Pharmaceutical Corporation Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)
WO1997017440A1 (en) * 1995-11-09 1997-05-15 Garvan Institute Of Medical Research Neuropeptide y-y5 receptor
WO1997020822A1 (en) * 1995-12-01 1997-06-12 Novartis Ag Quinazolin-2,4-diazirines as npy receptor antagonist
WO1997020820A1 (en) * 1995-12-01 1997-06-12 Novartis Ag Heteroaryl compounds
WO1997037998A2 (en) * 1996-04-08 1997-10-16 Bayer Corporation Neuropeptide y receptor y5 and nucleic acid sequence

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
BARD JONATHAN A ET AL: "Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 270, no. 45, 1995, pages 26762 - 26765, XP002187958, ISSN: 0021-9258 *
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1993, HERZOG HERBERT ET AL: "Molecular cloning, characterization, and localization of the human homolog to the reported bovine NPY Y3 receptor: Lack of NPY binding and activation.", XP002187960, Database accession no. PREV199396087299 *
DNA AND CELL BIOLOGY, vol. 12, no. 6, 1993, pages 465 - 471, ISSN: 1044-5498 *
GERALD C ET AL: "A RECEPTOR SUBTYPE INVOLVED IN NEUROPEPTIDE-Y-INDUCED FOOD INTAKE", NATURE, MACMILLAN JOURNALS LTD. LONDON, GB, vol. 382, 11 July 1996 (1996-07-11), pages 168 - 171, XP000612078, ISSN: 0028-0836 *
GERALD CHRISTOPHE ET AL: "Expression cloning and pharmacological characterization of a human hippocampal neuropeptide Y/peptide YY Y2 receptor subtype.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 270, no. 45, 1995, pages 26758 - 26761, XP002187957, ISSN: 0021-9258 *
HU Y ET AL: "IDENTIFICATION OF A NOVEL HYPOTHALAMIC NEUROPEPTIDE Y RECEPTOR ASSOCIATED WITH FEEDING BEHAVIOR", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 271, no. 42, 18 October 1996 (1996-10-18), pages 26315 - 26319, XP002040612, ISSN: 0021-9258 *
LARHAMMAR D ET AL: "CLONING AND FUNCTIONAL EXPRESSION OF A HUMAN NEUROPEPTIDE Y-PEPTIDE YY RECEPTOR OF THE Y1 TYPE", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 267, no. 16, 1992, pages 10935 - 10938, XP000612077, ISSN: 0021-9258 *
LUNDELL INGRID ET AL: "Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 270, no. 49, 1995, pages 29123 - 29128, XP002187959, ISSN: 0021-9258 *
ROSE PATRICIA M ET AL: "Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 270, no. 39, 1995, pages 22661 - 22664, XP002187956, ISSN: 0021-9258 *
See also references of WO9746250A1 *

Also Published As

Publication number Publication date
AU3295297A (en) 1998-01-05
WO1997046250A1 (en) 1997-12-11
EP1007073A1 (en) 2000-06-14

Similar Documents

Publication Publication Date Title
EP1007073A4 (en) PROCEDURES FOR EATING HABITS, COMPOUNDS SUITABLE FOR THESE PROCEDURES, AND DNA ENCODING A HYPOTHALAMIC ATYPICAL NEUROPEPTIDE Y / PEPTIDE YY RECEPTOR
ATE244304T1 (en) METHOD FOR ALTERING EATING BEHAVIOR, COMPOUNDS USABLE THEREFOR, AND DNA CODING A HYPOTHALAMIC ATYPICAL NEUROPEPTIDE Y/PEPTIDE YY RECEPTOR (Y5).
DE59705513D1 (en) Hydrogenation process
DE69712676D1 (en) Video encoding method
EP1107976A4 (en) ANTI-ENDOTOXIC, ANTIMICROBIAL CATIONIC PEPTIDES AND METHOD FOR THEIR USE
DE69711785D1 (en) Improved cartridge for an injection device
DE69518698D1 (en) Last injection time indicator for an injection pen
NO984452D0 (en) Procedure for Determining Stone's Compression Resistance
DE69841085D1 (en) Device for determining the nitrogen oxide concentration
DE60117726D1 (en) System and method for key conversion
IS5410A (en) New neuronal peptide Y antagonist (NPY)
EP0654947A4 (en) ENCODER AND METHOD FOR ENCODING.
DE19882508T1 (en) A memory-based VLSI architecture for image compression
ATE438590T1 (en) METHOD FOR CLEANING HIGHER DIAMOND STRUCTURE-LIKE COMPOUNDS AND PREPARATIONS CONTAINING SAME
DE69725127D1 (en) Tungsten oxide solution and process for its manufacture
DE69737229D1 (en) PEPTIDE WITH CORTISTATIN OR SOMATOSTATIN ACTIVITY, METHOD FOR THE PRODUCTION THEREOF AND ITS USE
EP1246686A4 (en) Rapid protein identification using antibody mixtures
DE10196688T1 (en) A decoder for trellis-based channel coding
DE69701744D1 (en) FILLING BODIES FOR COLUMN
DE59701829D1 (en) Slide block for a telescopic column
NO984463L (en) Purified Proteins, Recombinant DNA Sequences and Methods for Preparing Caffeine-Free Drinks
EP1019522A4 (en) CONNECTIONS AND METHODS FOR ADMINISTERING PNEUMOCOCCAL DNA
DE60027052D1 (en) METHOD AND SYSTEM FOR SELECTING IN-BAND CHANNELS AND FOR IDENTIFICATION THROUGH CHANNELS
ATA162297A (en) LOCKING VALVE FOR FLOW LIMITING
WO2001068869A3 (en) Human g-coupled protein receptor kinsaes and polynucleotides encoding the same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990104

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20020213

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20030917

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050830